Navigation Links
Otonomy Introduces Scientific Advisory Board
Date:3/30/2009

the ear for diagnostic purposes and the 3D anatomy of the inner ear. He was a clinical physiologist at the Institute for Sound and Vibrations Research, University of Southampton, England and did postdoctoral training at the National Institute for Environmental Health Sciences in North Carolina. Dr. Salt received his Ph.D. in cochlear physiology from the University of Birmingham, England, where he also earned his M.S. in neurocommunications. He was the winner of the 2008 Gold Medal Award from the Prosper Meniere Society and the 1999 Guyot Prize from the University of Groningen, The Netherlands, for "important work of great merits in the field of otological and biological research".

About Otonomy

Otonomy is an emerging biopharmaceutical company based in San Diego that is focused on the development and commercialization of novel treatments for diseases of the inner and middle ear. This field represents a large untapped opportunity with nearly 30 million Americans facing debilitating hearing and balance disorders. Currently, no approved drug treatments exist for these conditions. In addition, more than 5 million annual cases of ear infection are still treated with resistance-causing oral antibiotics or locally administered drugs that require surgical perforation of the ear drum. Otonomy is working in partnership with leading experts in the field to bring new drug therapies to these unserved patients. For more information, visit www.otonomy.com.

Editor's Note: Photographs available on request

    Media Contact
    Heidi Chokeir, Ph.D., or David Schull
    Russo Partners
    O (619) 528-2217
    M (858) 380-6584
    heidi.chokeir@russopartnersllc.com
    david.schull@russopartnersllc.com


'/>"/>
SOURCE Otonomy Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
2. PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace
3. DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
4. Lumenis(R) Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting
5. GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools
6. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
7. Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells
8. MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
9. Max Muscle Introduces First-Ever Probiotics Protein Bar
10. bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
11. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Soy Peptone. HSP A has been found to be effectinve ... ... December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a ... rates and yields. HSP-A has been found to be especially ...
(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
... issued the,following response to a press release distributed on ... achieved in the AIPPI in,AGA,s patent dispute with Occlutech. ... conducted before the AIPPI and that,organization agreed with the ... not been involved in any proceedings with Occlutech,in which ...
... Co. (OTC Bulletin Board:,AYXC) announced today it has ... of MiMedx, Inc., a development-stage medical device,company, based ... transaction, structured as a reverse merger,Alynx issued approximately ... and,approximately 3.7 million new shares of its preferred ...
... PharmAthene, Inc., a,biodefense company developing medical ... that it has appointed Joan Fusco,Ph.D. Senior ... brings more than twenty years of experience ... experience in a variety of,functional areas including, ...
Other Biology Technology:AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe 2Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc. 2Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc. 3PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations 2PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations 3
(Date:12/16/2009)... every drop of water is a high priority for grape growers ... and vines have to be irrigated to make it through the ... of the water applied to the vines zips right by the ... percent of the water that is applied is lost below the ... and vine roots," said Eve Hinckley, who worked on the project ...
(Date:12/16/2009)... superstitions and rituals can help them get psyched up ... drugs (NSAIDs), which many athletes gobble down before and ... good. , "These agents are treatments for the symptoms ... Warden, whose research at Indiana University focuses on musculoskeletal ... to exercise or train at a certain level, but ...
(Date:12/16/2009)... 15, 2009 Signal Hill, CA Tom Bowman, ... and president of Bowman Global Change, has developed a ... fourth Intergovernmental Panel on Climate Change (IPCC) report for ... the authentic scientific information they need to make informed ... created the new format as a means to clearly ...
Breaking Biology News(10 mins):Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4NSAIDs: Take 'em early and often when competing? Think again 2Bowman creates graphic translation of climate change data 2Clarient Reports Second Quarter Revenue Up 40 Percent 53673 1Clarient Reports Second Quarter Revenue Up 40 Percent 53673 2Clarient Reports Second Quarter Revenue Up 40 Percent 53673 3Clarient Reports Second Quarter Revenue Up 40 Percent 53673 4Clarient Reports Second Quarter Revenue Up 40 Percent 53673 5Clarient Reports Second Quarter Revenue Up 40 Percent 53673 6Clarient Reports Second Quarter Revenue Up 40 Percent 53673 7Clarient Reports Second Quarter Revenue Up 40 Percent 53673 8Clarient Reports Second Quarter Revenue Up 40 Percent 53673 9Clarient Reports Second Quarter Revenue Up 40 Percent 53673 10National Courage Award Winner Jordan Thomas to Participate in PGA Adapted Youth Golf Clinic 53668 1National Courage Award Winner Jordan Thomas to Participate in PGA Adapted Youth Golf Clinic 53668 2BioSpecifics Technologies Corp to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12 2009 13362 1BioSpecifics Technologies Corp to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12 2009 13362 2
... have received a $1.08 million grant from New York through ... research on the growth and development of stem cells and ... role specific genes and biological molecules play in stem cell ... for the grants are Robert Linhardt, the Ann and John ...
... syndrome, was thought to function in endocytosis. In the March ... ( www.jcb.org ), Eastman et al. identify an unexpected ... , Cells transport excess fats into lipid droplets (LDs), where ... little is known about LD formation and regulation. Spartin hadn,t ...
... are used to thinking of heart disease as a product ... eat and how much we exercise. There is another road ... increase in particulate air pollution is associated with an increase ... relatively new field of environmental cardiology -- a field that ...
Other Biology News:Rensselaer receives more than $2 million from New York State to fund stem cell research 2Rensselaer receives more than $2 million from New York State to fund stem cell research 3Inhaling a heart attack: How air pollution can cause heart disease 2Inhaling a heart attack: How air pollution can cause heart disease 3
...
... Sequencing Quality 96 Well ... BAC template preparation from 1.5ml ... suitable for automated fluorescent sequencing ... DNA; Utilizes ProPrep strategy which ...
Hybridization Buffer 3.6 ml...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
Biology Products: